Copyright
©The Author(s) 2017.
World J Gastroenterol. May 21, 2017; 23(19): 3513-3521
Published online May 21, 2017. doi: 10.3748/wjg.v23.i19.3513
Published online May 21, 2017. doi: 10.3748/wjg.v23.i19.3513
Figure 1 Flowchart of study design.
IBS: Irritable bowel syndrome; LHID: Longitudinal Health Insurance Database; SSRI: Selective serotonin reuptake inhibitor.
Figure 2 Comparison of the cumulative incidence of irritable bowel syndrome for selective serotonin reuptake inhibitor users and non-users.
SSRI: Selective serotonin reuptake inhibitor; IBS: Irritable bowel syndrome.
- Citation: Lin WT, Liao YJ, Peng YC, Chang CH, Lin CH, Yeh HZ, Chang CS. Relationship between use of selective serotonin reuptake inhibitors and irritable bowel syndrome: A population-based cohort study. World J Gastroenterol 2017; 23(19): 3513-3521
- URL: https://www.wjgnet.com/1007-9327/full/v23/i19/3513.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i19.3513